187 related articles for article (PubMed ID: 12767988)
1. Replicating parvoviruses that target colon cancer cells.
Malerba M; Daeffler L; Rommelaere J; Iggo RD
J Virol; 2003 Jun; 77(12):6683-91. PubMed ID: 12767988
[TBL] [Abstract][Full Text] [Related]
2. Targeting of autonomous parvoviruses to colon cancer by insertion of Tcf sites in the P4 promoter.
Malerba M; Nikolova D; Cornelis J; Iggo R
Cancer Gene Ther; 2006 Mar; 13(3):273-80. PubMed ID: 16151476
[TBL] [Abstract][Full Text] [Related]
3. Adenoviruses with Tcf binding sites in multiple early promoters show enhanced selectivity for tumour cells with constitutive activation of the wnt signalling pathway.
Fuerer C; Iggo R
Gene Ther; 2002 Feb; 9(4):270-81. PubMed ID: 11896466
[TBL] [Abstract][Full Text] [Related]
4. Replicating adenoviruses that target tumors with constitutive activation of the wnt signaling pathway.
Brunori M; Malerba M; Kashiwazaki H; Iggo R
J Virol; 2001 Mar; 75(6):2857-65. PubMed ID: 11222711
[TBL] [Abstract][Full Text] [Related]
5. Cell type- and promoter-dependent modulation of the Wnt signaling pathway by sodium butyrate.
Bordonaro M; Lazarova DL; Augenlicht LH; Sartorelli AC
Int J Cancer; 2002 Jan; 97(1):42-51. PubMed ID: 11774242
[TBL] [Abstract][Full Text] [Related]
6. The Yin-Yang of TCF/beta-catenin signaling.
Barker N; Morin PJ; Clevers H
Adv Cancer Res; 2000; 77():1-24. PubMed ID: 10549354
[TBL] [Abstract][Full Text] [Related]
7. TCF: Lady Justice casting the final verdict on the outcome of Wnt signalling.
Brantjes H; Barker N; van Es J; Clevers H
Biol Chem; 2002 Feb; 383(2):255-61. PubMed ID: 11934263
[TBL] [Abstract][Full Text] [Related]
8. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
9. gamma-catenin is regulated by the APC tumor suppressor and its oncogenic activity is distinct from that of beta-catenin.
Kolligs FT; Kolligs B; Hajra KM; Hu G; Tani M; Cho KR; Fearon ER
Genes Dev; 2000 Jun; 14(11):1319-31. PubMed ID: 10837025
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation.
Esufali S; Bapat B
Oncogene; 2004 Oct; 23(50):8260-71. PubMed ID: 15377999
[TBL] [Abstract][Full Text] [Related]
11. ITF-2, a downstream target of the Wnt/TCF pathway, is activated in human cancers with beta-catenin defects and promotes neoplastic transformation.
Kolligs FT; Nieman MT; Winer I; Hu G; Van Mater D; Feng Y; Smith IM; Wu R; Zhai Y; Cho KR; Fearon ER
Cancer Cell; 2002 Mar; 1(2):145-55. PubMed ID: 12086873
[TBL] [Abstract][Full Text] [Related]
12. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells.
Chen RH; McCormick F
Cancer Res; 2001 Jun; 61(11):4445-9. PubMed ID: 11389074
[TBL] [Abstract][Full Text] [Related]
13. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
Satoh S; Daigo Y; Furukawa Y; Kato T; Miwa N; Nishiwaki T; Kawasoe T; Ishiguro H; Fujita M; Tokino T; Sasaki Y; Imaoka S; Murata M; Shimano T; Yamaoka Y; Nakamura Y
Nat Genet; 2000 Mar; 24(3):245-50. PubMed ID: 10700176
[TBL] [Abstract][Full Text] [Related]
14. Synergistic cooperation between the beta-catenin signaling pathway and steroidogenic factor 1 in the activation of the Mullerian inhibiting substance type II receptor.
Hossain A; Saunders GF
J Biol Chem; 2003 Jul; 278(29):26511-6. PubMed ID: 12724325
[TBL] [Abstract][Full Text] [Related]
15. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways.
Araki Y; Okamura S; Hussain SP; Nagashima M; He P; Shiseki M; Miura K; Harris CC
Cancer Res; 2003 Feb; 63(3):728-34. PubMed ID: 12566320
[TBL] [Abstract][Full Text] [Related]
16. beta-Catenin regulates vascular endothelial growth factor expression in colon cancer.
Easwaran V; Lee SH; Inge L; Guo L; Goldbeck C; Garrett E; Wiesmann M; Garcia PD; Fuller JH; Chan V; Randazzo F; Gundel R; Warren RS; Escobedo J; Aukerman SL; Taylor RN; Fantl WJ
Cancer Res; 2003 Jun; 63(12):3145-53. PubMed ID: 12810642
[TBL] [Abstract][Full Text] [Related]
17. Requirement for a nuclear function of beta-catenin in Wnt signaling.
Cong F; Schweizer L; Chamorro M; Varmus H
Mol Cell Biol; 2003 Dec; 23(23):8462-70. PubMed ID: 14612392
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells.
Tan C; Costello P; Sanghera J; Dominguez D; Baulida J; de Herreros AG; Dedhar S
Oncogene; 2001 Jan; 20(1):133-40. PubMed ID: 11244511
[TBL] [Abstract][Full Text] [Related]
19. Beta-catenin/Tcf-1-mediated transactivation of cyclin D1 promoter is negatively regulated by thyroid hormone.
Natsume H; Sasaki S; Kitagawa M; Kashiwabara Y; Matsushita A; Nakano K; Nishiyama K; Nagayama K; Misawa H; Masuda H; Nakamura H
Biochem Biophys Res Commun; 2003 Sep; 309(2):408-13. PubMed ID: 12951064
[TBL] [Abstract][Full Text] [Related]
20. TCF transcription factors: molecular switches in carcinogenesis.
Roose J; Clevers H
Biochim Biophys Acta; 1999 Oct; 1424(2-3):M23-37. PubMed ID: 10528152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]